New twist boosts immunotherapy treatment in cancer patients

A new study explains why many tumors ignore immune boosting treatments. It points to a missing gene called MTAP and suggests that an older drug, DFMO, can switch a silenced alarm back on.

This STING (Stimulator of Interferon Genes) pathway is part…